VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q53296175 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000043.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q53296175‏
024 ‎‡a 0000-0003-0098-0873‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q53296175‏
100 0 ‎‡a Eun Kyung Lee‏ ‎‡9 es‏ ‎‡9 sl‏ ‎‡9 ast‏
400 0 ‎‡a Eun Kyung Lee‏ ‎‡c researcher (ORCID 0000-0003-0098-0873)‏ ‎‡9 en‏
400 0 ‎‡a イ・ウンギョン‏ ‎‡9 ja‏
400 0 ‎‡a Eun Kyung Lee‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's Acute Hyperglycemia Associated with Anti-Cancer Medication.‏
670 ‎‡a Author's Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades.‏
670 ‎‡a Author's Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial.‏
670 ‎‡a Author's DNA methylation of MAPK signal-inhibiting genes in papillary thyroid carcinoma‏
670 ‎‡a Author's Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer‏
670 ‎‡a Author's Interaction between alcohol consumption and methylenetetrahydrofolate reductase polymorphisms in thyroid cancer risk: National Cancer Center cohort in Korea.‏
670 ‎‡a Author's Lesion-Based Evaluation Predicts Treatment Response to Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study‏
670 ‎‡a Author's Letter: Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance (Endocrinol Metab 2014;29:536-44, Min Jung Jung et al.).‏
670 ‎‡a Author's Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study‏
670 ‎‡a Author's Natural Killer Cells and Thyroid Diseases‏
670 ‎‡a Author's Polymorphisms of ADIPOR1 and ADIPOR2 are associated with phenotypes of type 2 diabetes in Koreans.‏
670 ‎‡a Author's Postoperative simultaneous integrated boost-intensity modulated radiation therapy for patients with locoregionally advanced papillary thyroid carcinoma: preliminary results of a phase II trial and propensity score analysis.‏
670 ‎‡a Author's Risk factors for recurrence after therapeutic lateral neck dissection for primary papillary thyroid cancer.‏
670 ‎‡a Author's Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma‏
670 ‎‡a Author's Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro).‏
670 ‎‡a Author's The association of the BRAF‏
670 ‎‡a Author's The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.‏
670 ‎‡a Author's The binary presence or absence of lymph node metastasis or extrathyroidal extension is not associated with survival in papillary thyroid cancers: Implications for staging systems‏
670 ‎‡a Author's The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer‏
670 ‎‡a Author's Therapeutic potential of Dickkopf-1 in wild-type BRAF papillary thyroid cancer via regulation of β-catenin/E-cadherin signaling.‏
670 ‎‡a Author's Total thyroidectomy's association with survival in papillary thyroid cancers and the high proportion of total thyroidectomy in low-risk patients: Analysis of Korean nationwide data‏
670 ‎‡a Author's Tumor size and age predict the risk of malignancy in Hürthle cell neoplasm of the thyroid and can therefore guide the extent of initial thyroid surgery.‏
909 ‎‡a (orcid) 0000000300980873‏ ‎‡9 1‏
919 ‎‡a polymorphismsofadipor1andadipor2areassociatedwithphenotypesoftype2diabetesinkoreans‏ ‎‡A Polymorphisms of ADIPOR1 and ADIPOR2 are associated with phenotypes of type 2 diabetes in Koreans.‏ ‎‡9 1‏
919 ‎‡a naturalkillercellsandthyroiddiseases‏ ‎‡A Natural Killer Cells and Thyroid Diseases‏ ‎‡9 1‏
919 ‎‡a acutehyperglycemiaassociatedwithanticancermedication‏ ‎‡A Acute Hyperglycemia Associated with Anti-Cancer Medication.‏ ‎‡9 1‏
919 ‎‡a changesintheclinicopathologicalcharacteristicsandoutcomesofthyroidcancerinkoreaoverthepast4decades‏ ‎‡A Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades.‏ ‎‡9 1‏
919 ‎‡a longtermrecurrenceofsmallpapillarythyroidcanceranditsriskfactorsinakoreanmulticenterstudy‏ ‎‡A Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study‏ ‎‡9 1‏
919 ‎‡a definingradioiodinerefractorydifferentiatedthyroidcancerefficacyandsafetyoflenvatinibbyradioiodinerefractorycriteriaintheselecttrial‏ ‎‡A Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial.‏ ‎‡9 1‏
919 ‎‡a dnamethylationofmapksignalinhibitinggenesinpapillarythyroidcarcinoma‏ ‎‡A DNA methylation of MAPK signal-inhibiting genes in papillary thyroid carcinoma‏ ‎‡9 1‏
919 ‎‡a integrativeanalysisofgenomicandtranscriptomiccharacteristicsassociatedwithprogressionofaggressivethyroidcancer‏ ‎‡A Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer‏ ‎‡9 1‏
919 ‎‡a interactionbetweenalcoholconsumptionandmethylenetetrahydrofolatereductasepolymorphismsinthyroidcancerrisknationalcancercentercohortinkorea‏ ‎‡A Interaction between alcohol consumption and methylenetetrahydrofolate reductase polymorphisms in thyroid cancer risk: National Cancer Center cohort in Korea.‏ ‎‡9 1‏
919 ‎‡a lesionbasedevaluationpredictstreatmentresponsetolenvatinibforradioactiveiodinerefractorydifferentiatedthyroidcancerakoreanmulticenterretrospectivestudy‏ ‎‡A Lesion-Based Evaluation Predicts Treatment Response to Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study‏ ‎‡9 1‏
919 ‎‡a letterexpressionofglucagonlikepeptide1receptorinpapillarythyroidcarcinomaanditsclinicopathologicsignificanceendocrinolmetab20142953644minjungjungetal‏ ‎‡A Letter: Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance (Endocrinol Metab 2014;29:536-44, Min Jung Jung et al.).‏ ‎‡9 1‏
919 ‎‡a tumorsizeandagepredicttheriskofmalignancyinhurthlecellneoplasmofthethyroidandcanthereforeguidetheextentofinitialthyroidsurgery‏ ‎‡A Tumor size and age predict the risk of malignancy in Hürthle cell neoplasm of the thyroid and can therefore guide the extent of initial thyroid surgery.‏ ‎‡9 1‏
919 ‎‡a totalthyroidectomysassociationwithsurvivalinpapillarythyroidcancersandthehighproportionoftotalthyroidectomyinlowriskpatientsanalysisofkoreannationwidedata‏ ‎‡A Total thyroidectomy's association with survival in papillary thyroid cancers and the high proportion of total thyroidectomy in low-risk patients: Analysis of Korean nationwide data‏ ‎‡9 1‏
919 ‎‡a therapeuticpotentialofdickkopf1inwildtypebrafpapillarythyroidcancerviaregulationofβcateninecadherinsignaling‏ ‎‡A Therapeutic potential of Dickkopf-1 in wild-type BRAF papillary thyroid cancer via regulation of β-catenin/E-cadherin signaling.‏ ‎‡9 1‏
919 ‎‡a effectofexternalbeamradiotherapyvolumeonlocoregionalcontrolinpatientswithlocoregionallyadvancedorrecurrentnonanaplasticthyroidcancer‏ ‎‡A The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer‏ ‎‡9 1‏
919 ‎‡a binarypresenceorabsenceoflymphnodemetastasisorextrathyroidalextensionisnotassociatedwithsurvivalinpapillarythyroidcancersimplicationsforstagingsystems‏ ‎‡A The binary presence or absence of lymph node metastasis or extrathyroidal extension is not associated with survival in papillary thyroid cancers: Implications for staging systems‏ ‎‡9 1‏
919 ‎‡a associationofthebrafv600emutationwithprognosticfactorsandpoorclinicaloutcomeinpapillarythyroidcancerametaanalysis‏ ‎‡A The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.‏ ‎‡9 1‏
919 ‎‡a associationofthebraf‏ ‎‡A The association of the BRAF‏ ‎‡9 1‏
919 ‎‡a studyprotocolofmulticenterprospectivecohortstudyofactivesurveillanceonpapillarythyroidmicrocarcinomamaestro‏ ‎‡A Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro).‏ ‎‡9 1‏
919 ‎‡a studyprotocolofmulticenterprospectivecohortstudyofactivesurveillanceonpapillarythyroidmicrocarcinoma‏ ‎‡A Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma‏ ‎‡9 1‏
919 ‎‡a riskfactorsforrecurrenceaftertherapeuticlateralneckdissectionforprimarypapillarythyroidcancer‏ ‎‡A Risk factors for recurrence after therapeutic lateral neck dissection for primary papillary thyroid cancer.‏ ‎‡9 1‏
919 ‎‡a postoperativesimultaneousintegratedboostintensitymodulatedradiationtherapyforpatientswithlocoregionallyadvancedpapillarythyroidcarcinomapreliminaryresultsofaphase2trialandpropensityscoreanalysis‏ ‎‡A Postoperative simultaneous integrated boost-intensity modulated radiation therapy for patients with locoregionally advanced papillary thyroid carcinoma: preliminary results of a phase II trial and propensity score analysis.‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000505543597
996 ‎‡2 ISNI|0000000473836001
996 ‎‡2 ISNI|0000000480112845
996 ‎‡2 ISNI|0000000514765722
996 ‎‡2 ISNI|0000000512350806
996 ‎‡2 PLWABN|9814078486505606
996 ‎‡2 ISNI|0000000475355260
996 ‎‡2 ISNI|0000000474731631
996 ‎‡2 ISNI|0000000461022182
996 ‎‡2 ISNI|0000000049387358
996 ‎‡2 ISNI|0000000502793873
996 ‎‡2 SUDOC|067322867
996 ‎‡2 ISNI|0000000475192051
996 ‎‡2 ISNI|000000050844501X
996 ‎‡2 ISNI|0000000504866079
996 ‎‡2 SUDOC|249033992
996 ‎‡2 ISNI|0000000463358325
996 ‎‡2 ISNI|0000000463229806
996 ‎‡2 ISNI|0000000464692536
996 ‎‡2 ISNI|0000000054535845
996 ‎‡2 ISNI|0000000505550690
996 ‎‡2 LC|n 2009023255
996 ‎‡2 ISNI|0000000464364276
996 ‎‡2 DNB|1048737373
996 ‎‡2 ISNI|0000000483080199
996 ‎‡2 ISNI|0000000473803912
996 ‎‡2 ISNI|0000000492107752
996 ‎‡2 ISNI|0000000468681885
996 ‎‡2 ISNI|0000000463258797
996 ‎‡2 DNB|1057645516
996 ‎‡2 SUDOC|074302221
996 ‎‡2 ISNI|0000000502716659
996 ‎‡2 ISNI|0000000504168190
996 ‎‡2 ISNI|0000000473935085
996 ‎‡2 ISNI|0000000079897762
996 ‎‡2 ISNI|0000000492274710
996 ‎‡2 ISNI|0000000464895632
996 ‎‡2 ISNI|0000000503961234
996 ‎‡2 ISNI|0000000473365836
996 ‎‡2 NLA|000035222926
996 ‎‡2 NYNYRILM|49569
996 ‎‡2 ISNI|0000000467920813
996 ‎‡2 DNB|173044425
996 ‎‡2 ISNI|0000000026172215
996 ‎‡2 ISNI|0000000494000297
996 ‎‡2 ISNI|0000000493264813
996 ‎‡2 LC|no2005008552
996 ‎‡2 ISNI|0000000509575190
996 ‎‡2 ISNI|0000000479012273
996 ‎‡2 ISNI|0000000464839956
996 ‎‡2 ISNI|000000048394898X
996 ‎‡2 ISNI|0000000505750457
996 ‎‡2 ISNI|0000000477367441
996 ‎‡2 ISNI|0000000468670174
996 ‎‡2 ISNI|0000000505366551
996 ‎‡2 ISNI|000000051356438X
996 ‎‡2 ISNI|0000000477500476
996 ‎‡2 ISNI|0000000473943624
996 ‎‡2 ISNI|0000000513691792
996 ‎‡2 NUKAT|n 2019201306
996 ‎‡2 ISNI|0000000464520988
996 ‎‡2 SUDOC|14790143X
996 ‎‡2 ISNI|0000000463596948
996 ‎‡2 ISNI|000000050596640X
996 ‎‡2 ISNI|0000000464930813
996 ‎‡2 ISNI|0000000508119177
996 ‎‡2 ISNI|0000000513332968
996 ‎‡2 LC|n 2022012875
996 ‎‡2 ISNI|0000000489310573
996 ‎‡2 ISNI|0000000504168377
996 ‎‡2 ISNI|0000000468049687
996 ‎‡2 LC|n 80047241
996 ‎‡2 ISNI|0000000464444938
996 ‎‡2 SUDOC|123241146
996 ‎‡2 ISNI|0000000493179870
996 ‎‡2 CAOONL|ncf11905477
996 ‎‡2 ISNI|0000000479751869
996 ‎‡2 ISNI|0000000494024280
996 ‎‡2 ISNI|0000000479180891
996 ‎‡2 JPG|500270361
996 ‎‡2 ISNI|0000000473950883
996 ‎‡2 ISNI|0000000513671118
996 ‎‡2 DNB|1282670360
996 ‎‡2 ISNI|0000000464782857
996 ‎‡2 ISNI|0000000464921888
996 ‎‡2 ISNI|0000000464301494
996 ‎‡2 ISNI|0000000460992371
996 ‎‡2 ISNI|0000000514768982
996 ‎‡2 ISNI|0000000505548400
996 ‎‡2 DNB|1167111788
996 ‎‡2 ISNI|000000046779428X
996 ‎‡2 ISNI|0000000493140490
996 ‎‡2 ISNI|0000000505548216
996 ‎‡2 ISNI|000000046868199X
996 ‎‡2 LC|n 2014008067
996 ‎‡2 ISNI|000000046805008X
996 ‎‡2 RERO|A023696252
996 ‎‡2 ISNI|0000000492252423
996 ‎‡2 ISNI|0000000514455337
996 ‎‡2 LC|n 82004310
996 ‎‡2 ISNI|0000000356720755
996 ‎‡2 DNB|108056425X
996 ‎‡2 ISNI|0000000465052653
996 ‎‡2 ISNI|0000000492001042
996 ‎‡2 ISNI|0000000513683418
996 ‎‡2 ISNI|0000000513202442
996 ‎‡2 ISNI|000000051167450X
996 ‎‡2 ISNI|0000000431905179
996 ‎‡2 LC|nb2012025485
996 ‎‡2 ISNI|0000000504728944
996 ‎‡2 ISNI|0000000480203077
996 ‎‡2 ISNI|0000000513644865
996 ‎‡2 ISNI|0000000480265534
996 ‎‡2 ISNI|0000000473993015
996 ‎‡2 ISNI|0000000479038668
996 ‎‡2 ISNI|000000050494329X
996 ‎‡2 LC|n 2018070185
996 ‎‡2 NII|DA09539631
996 ‎‡2 ISNI|0000000473896135
996 ‎‡2 DNB|128992964
996 ‎‡2 ISNI|0000000473957129
996 ‎‡2 ISNI|0000000464302737
996 ‎‡2 ISNI|0000000512279245
996 ‎‡2 ISNI|0000000478569109
996 ‎‡2 SUDOC|111283450
996 ‎‡2 ISNI|0000000463229718
996 ‎‡2 ISNI|0000000480112968
996 ‎‡2 ISNI|0000000483506372
996 ‎‡2 ISNI|0000000493173137
996 ‎‡2 ISNI|0000000513810923
996 ‎‡2 ISNI|0000000504644732
996 ‎‡2 ISNI|0000000512501416
996 ‎‡2 ISNI|0000000512329409
996 ‎‡2 ISNI|0000000504543552
996 ‎‡2 ISNI|0000000463278042
996 ‎‡2 ISNI|0000000463310970
996 ‎‡2 ISNI|0000000480266019
996 ‎‡2 SUDOC|169836630
996 ‎‡2 J9U|987007403877905171
996 ‎‡2 LC|nr 94043069
996 ‎‡2 ISNI|0000000464774611
996 ‎‡2 ISNI|0000000465111182
996 ‎‡2 ISNI|0000000513360475
996 ‎‡2 ISNI|0000000473885970
996 ‎‡2 DNB|1038516552
996 ‎‡2 ISNI|0000000480265745
996 ‎‡2 NSK|000610670
996 ‎‡2 ISNI|0000000465089771
996 ‎‡2 ISNI|0000000514813149
996 ‎‡2 ISNI|0000000504520801
996 ‎‡2 ISNI|0000000514826580
996 ‎‡2 LC|n 2024039224
996 ‎‡2 ISNI|0000000512341109
996 ‎‡2 ISNI|0000000479093405
996 ‎‡2 ISNI|0000000473876169
996 ‎‡2 ISNI|0000000480265964
996 ‎‡2 ISNI|0000000492016658
996 ‎‡2 ISNI|0000000513668322
996 ‎‡2 ISNI|0000000505003566
996 ‎‡2 ISNI|0000000479013858
996 ‎‡2 ISNI|0000000494030170
996 ‎‡2 DNB|139819940
996 ‎‡2 ISNI|0000000468080721
996 ‎‡2 ISNI|0000000510833417
996 ‎‡2 ISNI|0000000463278034
996 ‎‡2 BNF|16757788
996 ‎‡2 DNB|1262899907
996 ‎‡2 ISNI|0000000461102799
996 ‎‡2 ISNI|0000000473795414
996 ‎‡2 LC|no2003027039
996 ‎‡2 ISNI|0000000516903316
996 ‎‡2 ISNI|0000000443588908
996 ‎‡2 ISNI|0000000480265999
996 ‎‡2 ISNI|0000000503957227
996 ‎‡2 ISNI|0000000473912860
996 ‎‡2 ISNI|0000000467821313
996 ‎‡2 ISNI|0000000508394603
996 ‎‡2 ISNI|0000000493211287
996 ‎‡2 NTA|30436620X
996 ‎‡2 ISNI|0000000504198963
996 ‎‡2 DNB|1257278401
996 ‎‡2 ISNI|0000000493179838
996 ‎‡2 ISNI|0000000479284850
996 ‎‡2 ISNI|0000000505550359
996 ‎‡2 LC|n 2024184814
996 ‎‡2 J9U|987007462550205171
996 ‎‡2 ISNI|0000000505733120
996 ‎‡2 ISNI|0000000473972695
996 ‎‡2 ISNI|0000000475122360
996 ‎‡2 LC|no2011069902
996 ‎‡2 ISNI|0000000473872379
996 ‎‡2 ISNI|000000049249027X
996 ‎‡2 NTA|146942388
996 ‎‡2 ISNI|0000000472525981
996 ‎‡2 ISNI|0000000464594661
996 ‎‡2 ISNI|0000000465016679
996 ‎‡2 DE633|pe30101248
996 ‎‡2 ISNI|0000000513463618
996 ‎‡2 ISNI|0000000504218637
996 ‎‡2 ISNI|0000000053432940
996 ‎‡2 ISNI|0000000477193701
996 ‎‡2 BNF|13519115
996 ‎‡2 ISNI|0000000474751261
996 ‎‡2 LC|no2017129977
996 ‎‡2 ISNI|0000000473807868
996 ‎‡2 ISNI|0000000475201755
996 ‎‡2 ISNI|0000000516825098
996 ‎‡2 ISNI|0000000474158601
996 ‎‡2 ISNI|0000000467789501
996 ‎‡2 ISNI|0000000473797006
996 ‎‡2 BIBSYS|90960393
996 ‎‡2 ISNI|0000000474065667
996 ‎‡2 ISNI|0000000463248812
996 ‎‡2 ISNI|0000000503938018
996 ‎‡2 ISNI|0000000464268639
996 ‎‡2 BNF|16666677
996 ‎‡2 ISNI|000000046865801X
996 ‎‡2 ISNI|0000000474200371
996 ‎‡2 ISNI|0000000460977956
996 ‎‡2 ISNI|0000000505576989
996 ‎‡2 ISNI|0000000464673810
996 ‎‡2 ISNI|0000000464444727
996 ‎‡2 ISNI|0000000050173736
996 ‎‡2 ISNI|000000046791443X
996 ‎‡2 ISNI|0000000503936522
996 ‎‡2 ISNI|0000000492337136
996 ‎‡2 ISNI|0000000505936593
996 ‎‡2 NII|DA03801254
996 ‎‡2 NLR|RU NLR AUTH 770180422
996 ‎‡2 ISNI|0000000464594864
996 ‎‡2 ISNI|000000046443772X
996 ‎‡2 DNB|1156978726
996 ‎‡2 ISNI|0000000473957161
996 ‎‡2 ISNI|0000000472426131
996 ‎‡2 DNB|1052913202
996 ‎‡2 ISNI|0000000464269367
996 ‎‡2 ISNI|0000000494068339
996 ‎‡2 ISNI|0000000512283025
996 ‎‡2 ISNI|0000000512522858
996 ‎‡2 ISNI|0000000465138721
996 ‎‡2 ISNI|0000000463277787
996 ‎‡2 ISNI|0000000516832925
996 ‎‡2 ISNI|000000050526183X
996 ‎‡2 BNF|16217116
996 ‎‡2 ISNI|0000000479075450
996 ‎‡2 ISNI|0000000492376522
996 ‎‡2 ISNI|0000000473895175
996 ‎‡2 ISNI|0000000473803453
996 ‎‡2 ISNI|0000000464595154
996 ‎‡2 ISNI|0000000430576537
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏